Friday 6 November 2026 Export LKFT’s income statement to Excel — free account

Lakefront Biotherapeutics - Sponsored ADR

Lakefront Biotherapeutics - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 321.9% from fiscal 2024.

Revenue: −95.4%
EPS: +198.9%
Free cash flow: +18.2%

Quarter to June 2026, against a year earlier

Operating cash flow growth 3 yrs

33.39 0.17 −0.51%

Follow LKFT

Alert me

Market cap: $2.2B
P/E: 0.0×
Fwd P/E: −15.3×
Dividend yield: —
F-score: 6/9
Altman Z: 8.43
Beneish M: 0.34
Dividend safety: n/a

Overview

Lakefront Biotherapeutics - Sponsored ADR (LKFT) Current ratio

Alert me on Current ratio

Lakefront Biotherapeutics - Sponsored ADR's current ratio at the end of the quarter to 30 June 2026 was 32.8×, up 12.7× from fiscal 2025 (20.1×). Over the past ten years it has ranged from 5.2× (fiscal 2015) to 20.1× (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LKFT/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Lakefront Biotherapeutics - Sponsored ADR current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LKFT/metrics/current-ratio">Lakefront Biotherapeutics - Sponsored ADR (LKFT) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	20.1×	102.14%
FY2024	10.0×	10.52%
FY2023	9.0×	11.22%
FY2022	8.1×	(5.53%)
FY2021	8.6×	1.55%
FY2020	8.5×	(17.61%)
FY2019	10.3×	69.77%
FY2018	6.0×	(13.37%)
FY2017	7.0×	(28.12%)
FY2016	9.7×	87.66%

Period	Current ratio	Change
Jun 2026	32.8×	7.75%
Mar 2026	30.5×	253.33%
Sep 2025	8.6×	6.78%
Jun 2025	8.1×	1.68%
33 more quarters	Free account

Against its own ten years

Low 5.2× High 20.1×

Ten-year median 8.6×

Current reading's percentile 100

Company	Current ratio
LKFT Lakefront Biotherapeutics - Sponsored ADR	32.8×
PVLA Palvella Therapeutics, Inc. compare	21.2×
IMNM Immunome, Inc. compare	15.1×
VERA Vera Therapeutics, Inc. compare	10.9×
ZYME Zymeworks Inc. compare	6.3×
AUPH Aurinia Pharmaceuticals Inc compare	6.1×
VCEL Vericel Corporation compare	5.1×
SEPN Septerna, Inc. compare	5.0×
BHVN Biohaven Ltd. compare	3.1×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Lakefront Biotherapeutics - Sponsored ADR (LKFT) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on LKFT

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on LKFT

Stockrow Weekly